Biomarkers for PTSD

Abstract

It is estimated that 10% to 20% of warfighters who have served in Iraq and Afghanistan have PTSD 1-4. An important limitation of these estimates is the reliance on self-report screening measures and clinical interviews to make the diagnosis of PTSD. These methods are subject to a number of biases, including underreporting of PTSD symptoms because of stigma of mental illness and concerns about adverse effects on careers, and exaggeration of symptoms in those seeking compensation for service- connected disability. Development of biomarkers of PTSD is critical for DOD and VA as objective indicators of PTSD for use in post-deployment medical screening, treatment selection, treatment outcome monitoring, disability evaluations, and for informing novel targets for treatment development.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jul 01, 2012
Accession Number
ADA619951

Entities

People

  • Charles R. Marmar

Organizations

  • New York University

Tags

DTIC Thesaurus Topics

  • Afghanistan
  • Anxiety Disorders
  • Biological Markers
  • Computational Biology
  • Department Of Defense
  • Department Of Veterans Affairs
  • Digital Data
  • Diseases And Disorders
  • Genetics
  • Health
  • Health Care
  • Health Services
  • Iraqi-War
  • Medical Screening
  • Mental Health
  • Test And Evaluation
  • Traumatic Stress Disorder

Fields of Study

  • Psychology

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Systems Analysis and Design